NYSEAM:BMNR
NYSEAM:BMNRSoftware

What Does Bitmine's 684% Surge Mean as Immersion Tech Hype Fuels Debate?

Thinking about what to do with Bitmine Immersion Technologies stock? You are definitely not alone. The ticker (BMNR) has turned heads recently, sparking plenty of debate. Let us unpack the story so far and set the stage for a close-up on valuation that might just help you make a more informed decision. Over the last year, Bitmine’s stock has certainly given investors reason to look twice. Despite some recent short-term dips, with a 5% drop in the past day and almost 7% in the past week, the...
NYSE:AD
NYSE:ADWireless Telecom

How Investors May Respond To Array Digital Infrastructure (AD) Profit Surge Amid Lower Revenues

Array Digital Infrastructure, Inc. released its second quarter 2025 earnings results earlier this month, reporting revenue of US$916 million and net income of US$31 million, compared to US$927 million in revenue and US$17 million net income for the same period last year. Despite a modest decrease in revenue, the company more than doubled its net income year over year, highlighting significant improvement in profitability or cost efficiency. We will explore how this increased net income,...
NYSE:ECVT
NYSE:ECVTChemicals

Ecovyst’s Share Buybacks and Updated Guidance Might Change the Case for Investing in ECVT

Ecovyst Inc. recently reported its second quarter 2025 earnings, completed a share repurchase of over 2.9 million shares for US$21.85 million, and provided updated full-year sales guidance of US$795 million to US$835 million, alongside improved expectations for its Zeolyst joint venture. An important development is the completion of a significant share buyback program, totaling more than 27.4 million shares repurchased since 2022, representing a substantial return of capital to...
NYSE:JPM
NYSE:JPMBanks

JPMorgan Chase (JPM): Is There Hidden Value in Its Current Stock Price?

JPMorgan Chase (JPM) has edged higher in recent days, landing on the radar for many investors looking to assess their next move in the banking sector. The bank’s modest price uptick has not been sparked by any headlines or dramatic earnings beats. Instead, it seems to reflect a confluence of steady business results and cautious optimism in the broader financial markets. When nothing dramatic makes the news, it often pays to look a little deeper, especially for a bank as influential as...
NYSE:BA
NYSE:BAAerospace & Defense

Should You Revisit Boeing After Shares Jump 35% Amid Commercial Plane Order Surge?

Thinking about what to do with Boeing stock right now? You are not alone. The past year has been a roller coaster, and investors have been watching every twist and turn with keen interest. After a dip earlier in the year, Boeing has rebounded, with shares up nearly 35% year-to-date and notching a 12% gain just in the past three months. That kind of momentum is hard to ignore, especially when you consider that the broader market has dealt with its fair share of turbulence. So, what is driving...
NasdaqGS:DXPE
NasdaqGS:DXPETrade Distributors

DXP Enterprises (DXPE) Is Up 5.3% After Strong Q2 Earnings and Expanded Acquisition Plans Has the Bull Case Changed?

DXP Enterprises, Inc. reported strong second quarter 2025 earnings, with sales rising to US$498.68 million and net income reaching US$23.61 million, both significantly above the prior year’s results. During the same period, management disclosed undrawn credit lines and increased liquidity, positioning the company to pursue at least three to four acquisitions in the second half of the year. We'll examine how DXP's strengthened balance sheet and acquisition pipeline may impact its outlook and...
NasdaqGM:LUNR
NasdaqGM:LUNRAerospace & Defense

Intuitive Machines (LUNR) Sees US$38 Million Net Loss In Recent Quarterly Performance

Intuitive Machines (LUNR) reported a notable quarterly performance on August 7, 2025, with sales increasing to $50.31 million, but a net loss of $38.59 million contrasted sharply with last year's profit. Despite securing a $9.8 million government contract and pursuing strategic mergers and acquisitions, the company's share price dropped 10.49% last week. This decline occurred as major indexes like the Dow and S&P 500 hovered near record highs, closing with slight gains over the same period...
NasdaqGM:USAR
NasdaqGM:USARMetals and Mining

USA Rare Earth (USAR) Reports Net Loss of US$143M for Q2 2025

USA Rare Earth (USAR) recently reported a net loss of USD 143 million for Q2 2025, signaling financial hurdles. However, a notable 82% rise in its share price last quarter coincides with strategic partnerships, including an MOU with Enduro Pipeline Services and a joint development agreement with ePropelled to produce neo magnets, reinforcing growth prospects despite market volatility. Concurrently, broader market trends saw marginal dips in major indices as stocks hovered near record highs...
NasdaqGM:GAMB
NasdaqGM:GAMBMedia

Gambling.com Group (GAMB) Expands Equity Buyback Plan By US$10 Million

Last week, Gambling.com Group (GAMB) reported its Q2 2025 earnings, which showed promising sales growth from $30.54 million to $39.59 million year-over-year, but also revealed a net loss of $13.42 million against a previous net income of $6.93 million. Additionally, the company expanded its equity buyback plan by $10 million. Despite these moves, GAMB's stock fell by 14%. This decline contrasts with broader market trends where major indices hovered near record highs and posted gains for a...
NYSE:GLOB
NYSE:GLOBIT

Globant (GLOB) Experiences 11% Drop Over Last Week

Globant (GLOB) is experiencing a period of pivotal developments, marked by new updates to its AI platform and the resignation of COO Patricia Pomies. However, the company's share price observed a 10.88% decline last week. This downturn coincided with a modest 1.3% overall market increase, leaving the company at odds with broader trends. Globant's recent product enhancements, which promise significant operational efficiency, and the anticipation of upcoming earnings results, may have added...
NasdaqCM:PROP
NasdaqCM:PROPOil and Gas

Prairie Operating (PROP) Sees US$35.7 Million Net Income Turnaround in Q2 2025 Earnings

Prairie Operating (PROP) recently announced its Q2 2025 earnings, reporting a significant turnaround with a net income of $35.7 million, compared to a net loss in the same quarter last year. Despite this positive financial performance and updated corporate guidance projecting robust production and net income for 2025, the company's stock saw a 24% decline over the past week. This move counteracted broader market trends, where major indexes hovered near record highs after two consecutive weeks...
NYSEAM:UAMY
NYSEAM:UAMYMetals and Mining

United States Antimony (UAMY) Revenue Soars To US$11 Million In Strong Quarter

United States Antimony (UAMY) experienced a notable quarter with a 63% increase in share price, benefiting from strong corporate developments. The company reaffirmed its revenue guidance for the year, projecting an optimistic outlook with revenues expected between $40 million and $50 million. Despite a slight drop in quarterly net income to $0.18 million, sales grew significantly to $10.53 million from $3.66 million year-over-year. Moreover, the company's business expansions, particularly in...
NYSE:HSY
NYSE:HSYFood

Hershey (HSY) Appoints Natalie Rothman As New Chief Human Resources Officer

Hershey (HSY) recently appointed Natalie Rothman as Chief Human Resources Officer, a move that comes amid several key executive changes and market trends. Over the last quarter, the company's share price increased by 14%, possibly influenced by its strategic leadership realignment, along with broader market movements following a second consecutive week of gains in major indexes. Although specific catalysts for this rise aren't clear, Hershey's new product collaborations, executive...
NasdaqGS:INSM
NasdaqGS:INSMBiotechs

Insmed (INSM) Gains As FDA Approves BRINSUPRI For New Market

Insmed (INSM) saw a significant price move of 87% over the past quarter, driven by pivotal product developments and regulatory milestones. The FDA's approval of BRINSUPRI as the first oral treatment for non-cystic fibrosis bronchiectasis was a key highlight, potentially opening up a substantial market opportunity. Meanwhile, the designation of Maxor Specialty Pharmacy as a limited distribution provider further strengthened the product's market presence. Despite reporting a net loss for Q2...